Howard G. Welgus Insider Trades & Stock Holdings

Director · Arcutis Biotherapeutics, Inc. · Latest filing Oct 15, 2026

Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($127.33K), net -$127.33K. Latest filing: disposed of 4.73K shares of $ARQT on Oct 15, 2026 at $26.93.

Trades on file

1

Open-market bought

$0

Open-market sold

$127.33K

Net open-market

-$127.33K

Shares held ($ARQT)

35.21K

Latest filing

Oct 15, 2026

Shares held by Howard G. Welgus

• $ARQT35.21K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Howard G. Welgus

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$ARQT	Sell (Open-market sale) 10b5-1	4.73K	$26.93	$127.33K	35.21K	-11.84%				Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Howard G. Welgus traded

• $ARQT

Frequently asked questions

Has Howard G. Welgus been buying or selling stock?

Howard G. Welgus has 0 open-market purchases and 1 open-market sale on file, net -$127.33K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Howard G. Welgus's latest insider trade?

disposed of 4.73K shares of $ARQT on Oct 15, 2026 at $26.93.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.